Insider trades
Jill Carroll, Director of Avalyn Pharma AVLN, has filed 1 purchase and 6 sales on the open market. Over the past 12 months that comes to a net purchase of $5M. The latest trade was on 05/01.
Jill Carroll
Director
- Company
- Avalyn Pharma AVLN
- First filing
- 23/05/15
- Trades
- 18 trades
- Buys / sales
- 1 / 6
- 12-month net buying
- $5M
- Last trade
- 05/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Avalyn PharmaAVLN | Open-market buy | 05/01 | 05/01 | 277,778 sh | $18.00 | $5,000,004 | +14.6% |
| Open-market sale | 24/03/21 | 24/03/25 | 504,263 sh | $70.55 | $35,575,754.65 | −25.4% | |
| Open-market sale | 23/12/14 | 23/12/18 | 504,263 sh | $49.13 | $24,774,441.19 | −20.3% | |
| Open-market sale | 23/05/31–23/06/01 | 23/06/02 | 340,720 sh2 trades | $41.71avg. | $14,212,714.6 | −12.0% | |
| Open-market sale | 23/05/11 | 23/05/15 | 638,417 sh2 trades | $45.01avg. | $28,736,222.75 | −18.4% |